Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
20.03.24
/
50%
€128.85
Target price
20.03.25
€145.64
Performance (%)
-1.40%
Price
26.04.24
€127.05
Summary
This prediction is currently active. With a performance of -1.40%, the BUY prediction for Neurocrine Bioscience by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 20.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.542% | 2.542% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $148.00 to $158.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
2.46%
26.04.24
26.04.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
18.46%
26.04.24
26.04.24